(Q36367826)

13 August 2017

1 reference

title

Pathogenesis of nonalcoholic steatohepatitis (NASH). (English)

1 reference

13 August 2017

0 references

0 references

Xiong Ma

1

1 reference

13 August 2017

Zhiping Li

series ordinal

2

1 reference

13 August 2017

publication date

1 January 2006

1 reference

Chinese journal of digestive diseases

13 August 2017

published in

1 reference

13 August 2017

volume

7

1 reference

13 August 2017

issue

1

1 reference

13 August 2017

page(s)

7-11

1 reference

Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Prevalence of and risk factors for fatty liver in a general population of Shanghai, China

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

The natural history of nonalcoholic fatty liver: a follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Liver fibrosis in overweight patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Association of nonalcoholic fatty liver disease with insulin resistance.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: further evidence for an etiologic association

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Metformin in non-alcoholic steatohepatitis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Steatohepatitis: a tale of two "hits"?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Partial purification of molecular weight 12 000 fatty acid binding proteins from rat brain and their effect on synaptosomal Na+-dependent amino acid uptake

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Fatty acid cytotoxicity to bovine lens epithelial cells: investigations on cell viability, ecto-ATPase, Na(+), K(+)-ATPase and intracellular sodium concentrations

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Apoptosis and liver diseases: recent concepts of mechanism and significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Cyclosporine A protects against arachidonic acid toxicity in rat hepatocytes: role of CYP2E1 and mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Etiopathogenesis of nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Plasma transforming growth factor-beta1 level and efficacy of alpha-tocopherol in patients with non-alcoholic steatohepatitis: a pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: effect of the nutritional status

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Mitochondrial abnormalities in non-alcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Nonalcoholic steatohepatitis: association of insulin resistance and mitochondrial abnormalities

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

NKT cells: facts, functions and fallacies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Sea-level fingerprinting as a direct test for the source of global meltwater pulse IA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Natural killer T cells as targets for therapeutic intervention in autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Murine leptin deficiency alters Kupffer cell production of cytokines that regulate the innate immune system

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Norepinephrine regulates hepatic innate immune system in leptin-deficient mice with nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

A central role for JNK in obesity and insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Reversal of obesity- and diet-induced insulin resistance with salicylates or targeted disruption of Ikkbeta

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Tumour necrosis factors receptor associated signalling molecules and their role in activation of apoptosis, JNK and NF-kappaB.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Protection from obesity-induced insulin resistance in mice lacking TNF-alpha function

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

Probiotics and antibodies to TNF inhibit inflammatory activity and improve nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1443-9573.2006.00237.X

10.1111/J.1443-9573.2006.00237.X

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference